Unirisco Galicia

José Antonio Vázquez García serves as President and is the firm's public-facing investment lead. Unirisco's decision-making integrates heavily with the University of Santiago de Compostela's technology transfer office, which screens faculty inventions and identifies commercially viable spin-outs. The firm's small team structure suggests a committee-oriented investment process rather than a single discretionary manager, though specific internal governance is not publicly detailed.

Unirisco was founded by the University of Santiago de Compostela in partnership with regional financial institutions to serve as the university's dedicated commercialization vehicle. The firm exclusively or near-exclusively invests in companies that originate from the university's research labs and faculties. It operates as a legally separate entity but maintains deep operational integration with the university's technology transfer infrastructure.

Unirisco invests at the seed and early-stage phases, typically providing first institutional capital to university spin-outs that have validated their core scientific thesis but have not yet generated commercial revenue. Investment tickets are generally modest by pan-European standards, in the €100,000 to €500,000 range, consistent with a proof-of-concept and early-commercialization mandate.

Unirisco operates exclusively as a direct investor into companies, not as a fund-of-funds or limited partner in other venture vehicles. Its balance-sheet structure — thought to be evergreen — allows it to hold positions through full commercialization cycles without the distribution mandates that govern standard 10-year venture funds.

Unirisco's sector exposure is dictated by the research strengths of the University of Santiago de Compostela: life sciences, advanced materials, industrial technology, information technology, and clean energy. Confirmed investments include Cebiotex in surgical biomaterials and Situm in indoor-positioning software. The firm does not invest in consumer internet, financial services, or other sectors unrelated to the university's scientific output.